ANXA5 and acute myeloid leukemia: Compared with monotherapy, combination treatment of AML cell lines with CX-5461 and AZD6738 for 48 h induced significantly increased apoptosis, as reflected by enhanced Annexin V positivity and substantially increased caspase 3 and PARP cleavage (Figs. 1a, b and S2).